Health Canada has stated that unauthorized injectable peptides cannot lawfully be compounded for human use, which covers all three components of the GLOW formulation
These protective benefits have been observed in the GI tract, liver, cardiovascular system, and brain [20, 36]
Systemic effects remain less certain because peptides are generally broken down during digestion, which reduces the amount that reaches circulation in active form
BPC-157 is typically administered via subcutaneous injection, based on a provider-guided protocol
Frontiers in Pharmacology
Well review your health history, discuss your wellness goals, and recommend individualized options based on your providers evaluation